Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 6,676 shares of the stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $4.03, for a total transaction of $26,904.28. Following the completion of the sale, the chief executive officer directly owned 125,389 shares in the company, valued at approximately $505,317.67. The trade was a 5.06% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Amit Gupta also recently made the following trade(s):
- On Monday, August 17th, Amit Gupta sold 6,785 shares of Cardlytics stock. The shares were sold at an average price of $3.97, for a total transaction of $26,936.45.
- On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The shares were sold at an average price of $4.39, for a total transaction of $42,319.60.
- On Thursday, July 2nd, Amit Gupta sold 6,498 shares of Cardlytics stock. The stock was sold at an average price of $4.39, for a total transaction of $28,526.22.
Cardlytics Price Performance
NASDAQ CDLX opened at $4.26 on Thursday. Cardlytics, Inc. has a 1 year low of $3.49 and a 1 year high of $32.80. The stock has a market capitalization of $24.75 million, a PE ratio of -0.23 and a beta of 0.62. The company’s 50 day simple moving average is $4.35 and its two-hundred day simple moving average is $6.95.
Wall Street Analysts Forecast Growth
CDLX has been the subject of several recent analyst reports. Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a research report on Thursday, June 18th. Lake Street Capital set a $10.00 price target on Cardlytics in a report on Friday, May 8th. Wall Street Zen raised Cardlytics from a “sell” rating to a “hold” rating in a report on Saturday, August 8th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Cardlytics in a report on Wednesday, July 8th. One research analyst has rated the stock with a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Sell” and an average target price of $10.00.
Read Our Latest Report on CDLX
Institutional Trading of Cardlytics
A number of hedge funds have recently made changes to their positions in the stock. Virtu Financial LLC purchased a new position in Cardlytics in the fourth quarter worth $39,000. Qube Research & Technologies Ltd bought a new stake in Cardlytics during the third quarter worth about $55,000. Marshall Wace LLP purchased a new position in shares of Cardlytics in the 2nd quarter worth about $59,000. Renaissance Technologies LLC bought a new position in shares of Cardlytics during the 4th quarter valued at about $62,000. Finally, Barclays PLC raised its holdings in shares of Cardlytics by 31,167.6% during the 4th quarter. Barclays PLC now owns 55,969 shares of the company’s stock valued at $64,000 after buying an additional 55,790 shares in the last quarter. 68.10% of the stock is owned by institutional investors.
About Cardlytics
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Recommended Stories
- Five stocks we like better than Cardlytics
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
